A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine
Condition:   Haemophilus InfluenzaIntervention:   Biological: Hib conjugate vaccineSponsors:   Jiangsu Province Centers for Disease Control and Prevention;   Chengdu Olymvax Biopharmaceuticals Inc.Completed - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2016 Category: Research Source Type: clinical trials